Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Inatherys
Inatherys develops monoclonal antibodies for cancer and inflammatory diseases.
Sector
Subsector
Location
Facet Biotech
Monoclonal antibodies for the treatment of cancer and multiple sclerosis.
Sector
Subsector
Keywords
Location
Celldex Therapeutics
Celldex develops antibodies to treat diseases with inadequate treatments.
Sector
Subsector
Location
total rounds
total raised
Oriental Baitai
Biopharmaceutical developer
Sector
Subsector
Location
M&A Details1
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 22.10.2015. Their latest investor Essex Woodlands Healthcare Partners. Their latest round Debt Financing
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Essex Woodlands Healthcare Partners
Essex Woodlands is a leading healthcare venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Göran Ando
current job
Madison Alley Global Ventures
MAGV is a strategic planning, capital and M&A advisory firm focused on digital marketing, media, and advertising technology.
Sector
Subsector
count Of Investments
count Of Exists
SLS Venture
SLS Venture is one of the largest investment funds in Scandinavia's life science sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders3
Thomas Feldthus
Thomas Feldthus is the Board Member at ResoTher Pharma ApS
organization founded
Thomas Feldthus
Kirsten Drejer
Dr. Drejer has more than 20 years of experience in the pharmaceutical industry. Before joining Symphogen, she held several scientific and managerial positions at Novo Nordisk A/S, including four years as Director of Diabetes Discovery, and three years as Corporate Facilitator. In addition to her service on Symphogen's board of directors, Dr. Drejer is also a member of the board of directors of Danisco A/S and Bioneer A/S. Her scientific experience includes research and development of drugs for the treatment of Diabetes and she was instrumental in the Insulin Analogue and Nasal Insulin programs of Novo Nordisk.
organization founded
Kirsten Drejer
John Haurum
Dr. Haurum received a D.Phil. in immunology from the Institute of Molecular Medicine, University of Oxford. Subsequently, he took up a position as Assistant Professor at the Danish Cancer Society and completed his medical training. He has extensive research experience in molecular immunology and biochemistry and has published more than 35 articles. He has served as a consultant for several Danish biotech companies, and holds a Scandinavian International Management Institute (SIMI) diploma in Managing Medical Product Innovation
organization founded
John Haurum
